VSCO Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Victoria's Secret & Co (VSCO) is not a strong buy for a beginner investor with a long-term focus at this time. While there are some positive signals, such as bullish moving averages and improving gross margins, the lack of strong growth in net income and EPS, combined with mixed analyst ratings and a neutral sentiment from hedge funds and insiders, suggests a cautious approach. Additionally, the stock's technical indicators and options data do not provide a compelling entry point for a long-term investment.
The technical indicators show mixed signals. The MACD is positive at 0.714, indicating bullish momentum, but it is contracting. RSI is neutral at 52.104, suggesting no clear overbought or oversold conditions. Moving averages are bullish (SMA_5 > SMA_20 > SMA_200), and the stock is trading near its pivot level of 52.354, with key resistance at 56.342 and support at 48.366. However, the stock trend analysis predicts a short-term decline of -1.66% in the next day and -3.83% in the next week, which does not favor immediate entry.
Bullish moving averages indicate upward momentum.
Analysts such as UBS and JPMorgan have raised price targets and maintain Buy/Overweight ratings.
Gross margin increased YoY, signaling operational improvements.
Net income and EPS declined YoY in Q4 2026, reflecting weaker profitability.
Mixed analyst ratings with some firms lowering price targets and maintaining Neutral/Hold ratings.
No significant hedge fund or insider trading activity to indicate strong institutional confidence.
In Q4 2026, revenue increased by 7.74% YoY to $2.27 billion, showing top-line growth. However, net income dropped by -4.66% YoY to $184 million, and EPS declined by -6.54% YoY to $2. Gross margin improved slightly to 39.27%, up 1.74% YoY, indicating some operational efficiency gains.
Analyst sentiment is mixed. JPMorgan, UBS, and Barclays maintain positive outlooks with Buy/Overweight ratings and raised price targets (e.g., UBS raised to $81). However, TD Cowen and BofA maintain Neutral/Hold ratings, citing concerns about near-term margin pressures. Jefferies recommends buying on weakness but lowered its price target to $65 from $70.
